Welcome to LookChem.com Sign In|Join Free

CAS

  • or
8-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-amine is a complex organic compound with the molecular formula C12H19N. It is a derivative of the s-indacen framework, which is a saturated analog of the indacen system. 8-methyl-1,2,3,5,6,7-hexahydro-s-indacen-4-amine features a nitrogen atom at the 4-position, which imparts basic properties, and a methyl group at the 8-position, contributing to its steric and electronic characteristics. It is a colorless to pale yellow solid and is soluble in organic solvents. The compound is of interest in organic chemistry and may have potential applications in the synthesis of pharmaceuticals and other specialty chemicals due to its unique structure and reactivity.

1995072-66-6

Post Buying Request

1995072-66-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1995072-66-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1995072-66-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,9,9,5,0,7 and 2 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1995072-66:
(9*1)+(8*9)+(7*9)+(6*5)+(5*0)+(4*7)+(3*2)+(2*6)+(1*6)=226
226 % 10 = 6
So 1995072-66-6 is a valid CAS Registry Number.

1995072-66-6Downstream Products

1995072-66-6Relevant articles and documents

CHEMICAL COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY

-

Paragraph 001067; 001070, (2018/08/12)

The present disclosure relates to novel sulfonylurea and sulfonyl thiourea compounds and related compounds and their use in treating a disease or condition responsive to modulation of cytokines such as IL-1β and IL-18, modulation of NLRP3 or inhibition of the activation of NLRP3 or related components of the inflammatory process.

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

-

Page/Page column 148; 149, (2016/09/15)

ABSTRACT The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1995072-66-6